Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

APRACLONIDINE HCL 0.5% DROPS

Apraclonidine
$6.9210per ML

Strength

5.75 mg/mL

Manufacturer

Sandoz Inc.

NDC

61314066510

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Last Updated

6/18/2025

Active Ingredients

APRACLONIDINE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020258

On Market Since

7/19/2009

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

1 alternative • Same active ingredient

APRACLONIDINE HCL 0.5% DROPS
Generic
61314066505•Sandoz Inc.
$10.7917
+56% more

Related Drugs

Same classification

RYNEX PSE LIQUID
Generic
00485020616•Edwards Pharmaceuticals, Inc.
$0.0364
per ML
SUDOGEST COLD AND ALLERGY TAB
Generic
00904535124•Major Pharmaceuticals
$0.0535
per EA
NASAL DECONGESTANT 30 MG TAB
Generic
36800043262•Topco Associates LLC
$0.0539
per EA
NASAL DECONGESTANT 30 MG TAB
Generic
36800043267•Topco Associates LLC
$0.0539
per EA
QC NASAL DECONGEST 30 MG TAB
Generic
63868080248•Chain Drug Marketing Association
$0.0553
per EA
LOHIST-D LIQUID
Generic
68047012016•Larken Laboratories, Inc.
$0.0587
per ML
SM NASAL DECONGEST 30 MG TAB
Generic
70677000501•Strategic Sourcing Services LLC
$0.0598
per EA
APRODINE TABLET
Generic
00904730224•Major Pharmaceuticals
$0.0611
per EA
APRODINE TABLET
Generic
00904730260•Major Pharmaceuticals
$0.0611
per EA
SM NASAL DECONGEST 30 MG TAB
Generic
70677000502•Strategic Sourcing Services LLC
$0.0641
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy